这款APP满足了我所有需求
这款伤寒论查阅APP让我彻底告别了翻阅纸质书籍的烦恼。它提供了详尽的伤寒论资料，还有各种实用的工具和功能，如笔记、提醒等。我使用后感觉非常满意
App is temporarily unavailable
Description
Screenshots
伤寒论查阅通 FAQ
-
Is 伤寒论查阅通 free?
Yes, 伤寒论查阅通 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 伤寒论查阅通 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 伤寒论查阅通 cost?
伤寒论查阅通 is free.
-
What is 伤寒论查阅通 revenue?
To get estimated revenue of 伤寒论查阅通 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Brazil yet.
Ratings History
伤寒论查阅通 Reviews
伤寒论查阅通 Installs
Last 30 days
伤寒论查阅通 Revenue
Last 30 days伤寒论查阅通 Revenue and Downloads
Gain valuable insights into 伤寒论查阅通 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
-
Cardona Bryan
- Languages
- English, Chinese
- Recent release
- 1.5 (8 months ago )
- Released on
- Jan 4, 2024 (11 months ago )
- Also available in
- China , Pakistan , Hong Kong SAR China , Hungary , Indonesia , Israel , Italy , South Korea , Kuwait , Lebanon , Malaysia , Nigeria , Netherlands , Argentina , Portugal , Romania , Russia , Saudi Arabia , Sweden , Singapore , Türkiye , Ukraine , United States , South Africa , United Kingdom , United Arab Emirates , Australia , Azerbaijan , Belgium , Chile , Colombia , Germany , Dominican Republic , Algeria , Ecuador , France , Spain , Egypt , Switzerland , Greece , Vietnam , Austria , Kazakhstan , Taiwan , Ireland , Thailand , Finland , Brazil , Canada , India , Mexico , Poland , Czechia , Philippines , Peru , New Zealand , Norway , Japan , Denmark
- Last Updated
- 3 months ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.